ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Lung Cancer

Breast Cancer trials near St Louis, MO, USA:

Cryoablation vs Lumpectomy in T1 Breast Cancers (COOL-IT)

This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a ...

Enrolling
Breast Cancer
Breast Neoplasm
Device: Endocare SlimLine Cryoprobe
Procedure: Lumpectomy
The Washington University
The Washington University

Saint Louis, Missouri, United States

This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer...

Active, not recruiting
Breast Cancer
Procedure: Surgical resection of breast tumor
Drug: ARV-471

Phase 2

Arvinas
Arvinas

Saint Louis, Missouri, United States and 48 other locations

to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...

Enrolling
Locally Advanced Breast Cancer
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

Sarah Cannon Research Institute
Sarah Cannon Research Institute

Saint Louis, Missouri, United States and 10 other locations

The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy [paclitaxel] and ave ...

Active, not recruiting
Breast Cancer Metastatic
Biological: Pelareorep
Drug: Paclitaxel

Phase 2

Oncolytics Biotech

Saint Louis, Missouri, United States and 17 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo

Saint Louis, Missouri, United States and 226 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Saint Louis, Missouri, United States and 57 other locations

dose of MEN1611 to be used in combination with Trastuzumab with/without Fulvestrant for the treatment of advanced or metastatic HER2-positive breast...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Fulvestrant
Drug: MEN1611

Phase 1

Menarini
Menarini

Saint Louis, Missouri, United States and 26 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials (AFT)

Saint Louis, Missouri, United States and 114 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Phase 3

Pfizer
Pfizer

Saint Louis, Missouri, United States and 324 other locations

human epidermal receptor 2-negative (HER2)- palbociclib-resistant breast cancer, and to determine the recommended Phase 2 dose (RP2...

Active, not recruiting
Breast Cancer
Drug: ribociclib
Drug: TTI-101

Phase 1, Phase 2

Tvardi Therapeutics

Saint Louis, Missouri, United States and 5 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems